Advisor Group Holdings, Inc. Sesen Bio, Inc. Transaction History

Advisor Group Holdings, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.49 - $0.61 $4,483 - $5,581	-9,150 Reduced 29.85%	21,500 $13,000
Q2 2022 Aug 10, 2022	SELL	$0.38 - $0.89 $19 - $44	-50 Reduced 0.16%	30,650 $25,000
Q1 2022 May 04, 2022	SELL	$0.58 - $0.86 $3,450 - $5,117	-5,950 Reduced 16.23%	30,700 $18,000
Q3 2021 Nov 05, 2021	BUY	$0.77 - $4.91 $8,855 - $56,465	11,500 Added 45.73%	36,650 $29,000
Q2 2021 Aug 02, 2021	BUY	$2.18 - $4.66 $22,127 - $47,299	10,150 Added 67.67%	25,150 $116,000
Q1 2021 May 13, 2021	BUY	$1.3 - $3.24 $1,300 - $3,240	1,000 Added 7.14%	15,000 $39,000
Q4 2020 Feb 10, 2021	BUY	$1.01 - $1.77 $12,120 - $21,240	12,000 Added 600.0%	14,000 $19,000
Q1 2020 May 18, 2020	BUY	$0.39 - $1.03 $780 - $2,060	2,000 New	2,000 $1,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.